Cronos Group 10K Form

Sell

46

CRON
Cronos Group

Last Price:

2.12

Seasonality Move:

49.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-26	10K	CRON/Cronos Group Annual
2020-11-05	10Q	CRON/Cronos Group Quarterly
2020-08-06	10Q	CRON/Cronos Group Quarterly
2020-05-08	10Q	CRON/Cronos Group Quarterly
2020-03-30	10K	CRON/Cronos Group Annual
2020-03-02	10K	CRON/Cronos Group Annual

Receive CRON News And Ratings

See the #1 stock for the next 7 days that we like better than CRON

CRON Financial Statistics

Sales & Book Value

Annual Sales:	$87.24M
Cash Flow:	$828K
Price / Cash Flow:	77.35
Annual Sales:	$2.77
Price / Book:	0.82

Profitability

EPS (TTM):	-0.14430
Net Income (TTM):	$-57.43M
Gross Margin:	$11.91M
Return on Equity:	-5.24%
Return on Assets:	-5.08%

Cronos Group Earnings Forecast

Key Cronos Group Financial Ratios

The Gross Profit Margin over the past 10 years for CRON is 13.65%.
The Selling, General & Administrative Expenses for CRON have been equal to 92.77% of Gross Profit Margin.
The Research & Development expenses have been 6.70% of Revenue.
The Interest Expense is -0.01% of Operating Income.
The Net Earning history of CRON is -84.78% of Total Revenues.
Per Share Earnings over the last 10 years have been positive in 4 years.

Cronos Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	CRON
CUSIP:	22717L
Website:	thecronosgroup.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	28.29
Quick Ratio:	26.67

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

CRON Technical Analysis vs Fundamental Analysis

Sell

46

Cronos Group (CRON) is a Sell

Is Cronos Group a Buy or a Sell?

Cronos Group stock is rated a Sell
The current Cronos Group [CRON] share price is $2.17. The Score for CRON is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.